These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9660993)

  • 1. Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.
    Lister PD; Sanders WE; Sanders CC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1610-9. PubMed ID: 9660993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro study of antibacterial activity of cefepime (Axepim) against gram negative bacteria: comparison with cephalosporins and other beta-lactams].
    Vachée A; Devalckenaere A; Husson MO; Izard D
    Pathol Biol (Paris); 1996 Feb; 44(2):132-7. PubMed ID: 8761598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.
    McGrath BJ; Bailey EM; Lamp KC; Rybak MJ
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2741-6. PubMed ID: 1482142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
    Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
    Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model.
    Cappelletty DM
    Antimicrob Agents Chemother; 1999 Jan; 43(1):129-33. PubMed ID: 9869577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
    Bonfiglio G; Marchetti F
    Chemotherapy; 2000; 46(4):229-34. PubMed ID: 10859428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment.
    Turcotte A; Simard M; Morin NJ; Beauchamp D; Bergeron MG
    Antimicrob Agents Chemother; 1997 Feb; 41(2):401-9. PubMed ID: 9021198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Belgian multicentre study on the in vitro activity of cefepime against gram-negative bacilli.
    Verbist L; Glupczynski Y
    Acta Clin Belg; 1996; 51(1):28-35. PubMed ID: 8669160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
    Burgess DS; Summers KK; Hardin TC
    Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-spectrum cephalosporinase in Acinetobacter baumannii.
    Rodríguez-Martínez JM; Nordmann P; Ronco E; Poirel L
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3484-8. PubMed ID: 20547808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
    Mimoz O; Jacolot A; Leotard S; Hidri N; Samii K; Nordmann P; Petitjean O
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3304-8. PubMed ID: 9835534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
    J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study].
    Cavallo JD; Leblanc F; Fabre R
    Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the activity of beta-lactams against Pseudomonas aeruginosa according to phenotypes of resistance].
    Bert F; Briaud I; Branger C; Lambert-Zechovsky N
    Pathol Biol (Paris); 1996 May; 44(5):329-32. PubMed ID: 8758469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
    Jones RN; Salazar JC; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model.
    Tessier PR; Nicolau DP; Onyeji CO; Nightingale CH
    Chemotherapy; 1999; 45(4):284-95. PubMed ID: 10394012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and beta-lactams tested against gram-negative bacilli.
    Sader HS; Huynh HK; Jones RN
    Diagn Microbiol Infect Dis; 2003 Nov; 47(3):547-50. PubMed ID: 14596974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
    Martínez-Beltrán J; Cantón R; Liñares J; García de Lomas J; Gimeno C; Tubau F; Baquero F
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer antipseudomonal cephalosporins.
    Watanabe NA
    J Chemother; 1996 Feb; 8 Suppl 2():48-56. PubMed ID: 8738846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.